Background: Previous studies have suggested that impaired fetal and childhood growth are associated with an increased risk of schizophrenia, but the association of pre-adult growth with non-clinical psychotic symptoms (psychosis-like symptoms) in children is not known.

Aims: To explore the associations of body size at birth and age 7.5 years with childhood psychosis-like symptoms.

Method: Prospective cohort of children followed up from birth to age 12: the ALSPAC cohort.

Results: Data on 6000 singleton infants born after 37 weeks of gestation. A one standard deviation increase in birth weight was associated with an 18% reduction in the risk of definite psychosis-like symptoms after adjusting for age and gestation (Odds ratio (OR) = 0.82, 95% CI = 0.73-0.92, P = 0.001). This association was partly confounded by maternal anthropometry, smoking during pregnancy, socioeconomic status and IQ. A similar association was seen for birth length and psychosis-like symptoms, which disappeared after controlling for birth weight. There was little evidence for an association of 7-year height or adiposity with psychosis-like symptoms.

Conclusions: Measures of impaired fetal, but not childhood, growth are associated with an increased risk of psychosis-like symptoms in 12-year-olds.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802530PMC
http://dx.doi.org/10.1192/bjp.bp.108.051730DOI Listing

Publication Analysis

Top Keywords

psychosis-like symptoms
16
fetal childhood
12
childhood growth
12
growth non-clinical
8
non-clinical psychotic
8
psychotic symptoms
8
symptoms 12-year-olds
8
impaired fetal
8
growth associated
8
associated increased
8

Similar Publications

Recent advancements in the role of phytochemicals and medicinal plants in prophylaxis and management of Alzheimer's disease.

Iran J Basic Med Sci

January 2024

Neurotherapeutics Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, U.P., India.

Article Synopsis
  • - Medicinal plants and their phytochemicals are being studied for treating neurodegenerative disorders, particularly Alzheimer's disease (AD), as there's currently no FDA-approved drug that targets AD directly.
  • - Various plant-derived compounds, like paenol and flavonoids, have shown effectiveness against key mechanisms involved in AD, including inflammation and amyloid toxicity, with many clinical trials currently investigating their potential.
  • - The review highlights recent advancements over the past five years in using these natural substances in AD research, emphasizing the need for further exploration to achieve better neurorestoration outcomes.
View Article and Find Full Text PDF

Purpose This study estimated risk of incident mental disorders in adulthood associated with both transient and persistent adolescent psychotic experiences (PEs). Methods A nested case-control design was used within the Avon Longitudinal Study of Parents and Children (ALSPAC), a birth cohort study which recruited expectant mothers from 1991-1992. Participants consisted of 8822 offspring of ALSPAC mothers who completed the Psychosis-like Symptoms Interview Questionnaire (PLIKSi-Q).

View Article and Find Full Text PDF

Background And Hypothesis: Social cognitive impairments are central to psychosis, including lower severity psychosis-like experiences (PLEs). Nonetheless, progress has been hindered by social cognition's poorly defined factor structure, as well as limited work examining the specificity of social cognitive impairment to psychosis. The present study examined how PLEs relate to social cognition in the context of other psychopathology dimensions, using a hierarchical factors approach to social cognition.

View Article and Find Full Text PDF

We used a probabilistic reversal learning task to examine prediction error-driven belief updating in three clinical groups with psychosis or psychosis-like symptoms. Study 1 compared people with at-risk mental state and first episode psychosis (FEP) to matched controls. Study 2 compared people diagnosed with treatment-resistant schizophrenia (TRS) to matched controls.

View Article and Find Full Text PDF

Variability in white matter structure relates to hallucination proneness.

Neuroimage Clin

September 2024

University of Maastricht, Department of Neuropsychology and Psychopharmacology, Maastricht, The Netherlands; Max Planck Institute for Human and Cognitive Sciences, Department of Neuropsychology, Leipzig, Germany. Electronic address:

Hallucinations are a prominent transdiagnostic psychiatric symptom but are also prevalent in individuals who do not require clinical care. Moreover, persistent psychosis-like experience in otherwise healthy individuals may be related to an increased risk to transition to a psychotic disorder. This suggests a common etiology across clinical and non-clinical individuals along a multidimensional psychosis continuum that may be detectable in structural variations of the brain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!